Summary Safety Review - Atypical...
Dataset description:
Health Canada reviewed the potential risk of DRESS with the use of atypical antipsychotics, following the manufacturers’ voluntary update of the product safety information for Zyprexa...
There are no views created for this resource yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | April 17, 2026 |
| Metadata last updated | April 17, 2026 |
| Created | April 17, 2026 |
| Format | HTML |
| License | ca-ogl-lgo |
| Has views | False |
| Id | 2dceb3e8-e9a3-4327-a4c3-be131676241f |
| Package id | 7b066627-c2c8-4b30-9a81-6333796e3c74 |
| Position | 1 |
| State | active |